Scientific poster: High-speed analysis of pramipexole following the draft guidance of international harmonisation of pharmacopoeias
In recent years, ultra-high performance liquid chromatography (hereinafter, UHPLC) has been widely adopted in the pharmaceutical field to improve efficiency and productivity in analytical work.
Responding to these situations, General Chapter <621> CHROMATOGRAPHY in the 40th Edition of the United States Pharmacopeia (USP) and “Adjustment of chromatographic condition” in the 8th Edition of the European Pharmacopeia (EP) allow changes in high speed analysis conditions within a range that conforms to the system suitability test.
Related content from this organisation
- Scientific Poster & Whitepaper Gallery 2019
- Scientific poster: High-speed analysis of pramipexole following the draft guidance of international harmonisation of pharmacopoeias
- Shimadzu Europa GmbH
- Scientific Poster: Quantitation of monoclonal antibody infliximab in human plasma by LC-MS/MS using Fab-selective limited proteolysis nSMOL technology
- Shimadzu partners with Protein Metrics to provide advanced solutions for biotherapeutic protein analysis